DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
von Minckwitz G, Procter M, de Azambuja E. et al. APHINITY Steering Committee and Investigators.
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer.
N Engl J Med 2017;
377 (02) 122-131
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.